Open AccessHistologic Alterations from Neoadjuvant Chemotherapy in High‐Grade Extremity Soft Tissue Sarcoma: Clinicopathological Correlation
Author(s) -
Lucas David R.,
Kshirsagar Malti P.,
Biermann J. Sybil,
Hamre Merlin R.,
Thomas Dafydd G.,
Schuetze Scott M.,
Baker Laurence H.
Publication year - 2008
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2007-0220
Subject(s) - medicine , sarcoma , soft tissue , chemotherapy , osteosarcoma , soft tissue sarcoma , grading (engineering) , neoadjuvant therapy , pathology , oncology , radiology , cancer , civil engineering , breast cancer , engineering
Learning Objectives After completing this course, the reader will be able to: Use the correlation of all data from clinical, imaging, and histopathologic observations by a multidisciplinary tumor board in the prognosis of patients with soft tissue sarcoma. Interpret the prognostic value of histologic response to chemotherapy in soft tissue sarcoma in contrast to its value in osteosarcoma and Ewing's sarcoma. Evaluate the profound histologic alterations induced by neoadjuvant chemotherapy in soft tissue sarcomas.Access and take the CME test online and receive 1 AMA PRA Category 1 Credit ™ at CME.TheOncologist.com